Indications
Therapeutic Asset Ratings
18,140 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Etoposide
Acute Leukemia
SWOG Cancer Research Network
P2/3
B
(63)
Etoposide
Glioblastoma
Sichuan Honghe Biotechnology Co., Ltd.
P2/3
B
(63)
Fampridine
Optic Neuritis
Courtney Casserly
P2/3
B
(63)
Fludarabine
Osteopetrosis
Masonic Cancer Center, University of Minnesota
P2/3
B
(63)
Isavuconazole
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P2/3
B
(63)
L-Huperzine A
Alzheimer Disease
Wanbangde Pharmaceutical Group Co., LTD
P2/3
B
(63)
Lidocaine
Cancer-Related Condition
National and Kapodistrian University of Athens
P2/3
B
(63)
Nogitecan
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)
P2/3
B
(63)
Nogitecan
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)
P2/3
B
(63)
Olaparib
Castration-Resistant Prostate Carcinoma
AstraZeneca
P2/3
B
(63)
Oxaliplatin
Hyperglycemia
Chung Shan Medical University
P2/3
B
(63)
Paxalisib
Glioblastoma
Institute of Cancer Research, United Kingdom
P2/3
B
(63)
Pentoxifylline
Peripheral Neuropathy
Tanta University
P2/3
B
(63)
Prednisone
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
National Cancer Institute (NCI)
P2/3
B
(63)
Prednisone
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
University of Washington
P2/3
B
(63)
Prednisone
Intravascular Large B-Cell Lymphoma
Northwestern University
P2/3
B
(63)
Prednisone
T-Cell/Histiocyte Rich Large B Cell Lymphoma
Ruijin Hospital
P2/3
B
(63)
Quizartinib
Myelodysplastic Syndrome
M.D. Anderson Cancer Center
P2/3
B
(63)
Vincristine Sulfate
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)
P2/3
B
(63)
Vinorelbine Ditartrate
Cancer Of Unknown Primary Site
National Cancer Institute (NCI)
P1/2
B
(63)
Zorifertinib
Metastatic Malignant Neoplasm In The Brain
Alpha Biopharma (Jiangsu) Co., Ltd.
P2/3
B
(63)
5-hydroxytryptophan
Major Depressive Disorder
University of Utah
P4
B
(62)
Abemaciclib
Breast Cancer
Fudan University
P4
B
(62)
Abemaciclib
Her2-Receptor Negative Breast Cancer
Jonsson Comprehensive Cancer Center
P4
B
(62)
Apixaban
Hepatocellular Carcinoma
Mansoura University
P4
B
(62)
Showing 3026 to 3050 of 18,140 assets
Previous
Page 122 of 726
Next